Global Heparin Market to Reach US$ 8.1 Billion by 2027, Propelled by the Increasing Prevalence of Numerous Medical Ailments

April 19, 2020

The latest report by IMARC, titled “Heparin Market: Global Industry Trends, Size, Growth, Opportunity and Forecast 2022-2027”, finds that the global heparin market size reached US$ 6.9 Billion by 2021. Heparin, also known as unfractionated heparin (UFH), is a naturally occurring glycosaminoglycan, which is used as an anticoagulant or a blood thinner. It is utilized post surgeries, dialysis and blood transfusion and is usually injected into the muscle or veins to break up clots and maintain smooth fluidity of the blood. It is also used widely to administer major orthopedic procedures, such as hip and knee replacements. In recent years, heparin has gained momentum due to the extensive adoption of this product for treating heart conditions and unstable angina.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of the associated industries. These observations will be integrated into the report.

Global Heparin Market Trends:

One of the primary factors driving the market is the increasing prevalence of numerous medical ailments, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Additionally, heparin has proven its efficacy for venous thromboembolism and cardiovascular disorders (CVDs). Other than this, the easy availability of synthetic and semi-synthetic heparin mimetics that help cure coagulation, cancer, and inflammatory diseases, is positively influencing the market growth. Besides this, biopharmaceutical companies are introducing innovative medicines to improve the therapeutic potential of the drug and minimize its side-effects thus accelerating the product adoption rate. Moreover, the numerous technological upgradations in the field of carbohydrate synthesis, including coupling reactions, block preparation and the launch of convergent strategies, are catalyzing the market growth. Furthermore, extensive investment by the government of various nations for the improvement of healthcare facilities and vigorous research and development (R&D) activities to launch heparin with ultra-low molecular weight are creating lucrative growth opportunities for key players. Looking forward, IMARC Group expects the market value to reach US$ 8.1 Billion by 2027, expanding at a CAGR of 2.57% during the forecast period (2022-2027).

Market Summary:

  • Based on the product type, the market has been divided into unfractionated, low molecular wight (LMWH), and ultra-low molecular weight (ULMWH) heparin.
  • On the basis of the source, the market has been bifurcated into bovine and porcine.
  • Based on the mode of administration, the market has been segregated into oral and parental.
  • On the basis of the application, the market has been categorized into atrial fibrillation and heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others.
  • Based on the end user, the market has been segmented into hospitals, clinics, homecare settings, ambulatory surgical centers, and others.
  • On the basis of the distribution channel, the market has been divided into hospital pharmacies, retail pharmacies, drug stores, online stores, and others.
  • Region-wise, the market has been classified into Europe, North America, Asia Pacific, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has also been analyzed, with some of the key players being GlaxoSmithKline Plc, Shenzhen Hepalink Pharmaceutical Co., Ltd., Pfizer Inc., LEO Pharma A/S, Sanofi S.A., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Aspen Holdings, Baxter International Inc., Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Sandoz International GmbH, Opocrin S.p.A., Sichuan Deebio Pharmaceutical Co., Ltd., and Dongying Tiandong Pharmaceutical Co., Ltd.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

30 N Gould St Ste R
Sheridan, WY 82801 USA
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Heparin Market to Reach US$ 8.1 Billion by 2027, Propelled by the Increasing Prevalence of Numerous Medical Ailments
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More